Agios Pharmaceuticals | AGIO - Trade Creditors


Agios Pharmaceuticals reported $13.75M in Trade Creditors for its fiscal quarter ending in March of 2026.





Trade Creditors Change Date
AbbVie USD 3.59B 28.65B Dec/2025
Agios Pharmaceuticals USD 13.75M 4.61M Mar/2026
Alnylam Pharmaceuticals USD 126.63M 10.91M Mar/2026
Amgen USD 19.52B 1.37B Mar/2026
Arrowhead Research USD 30.75M 2.19M Mar/2026
Astellas Pharma JPY 199.75B 17.8B Mar/2026
AstraZeneca USD 22.51B 2.78B Mar/2026
Bayer EUR 6.59B 496M Mar/2026
Biogen USD 358.5M 73.5M Mar/2026
BioMarin Pharmaceutical USD 793.15M 34.12M Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Eli Lilly USD 5.03B 350M Mar/2026
Exelixis USD 24.15M 5.47M Mar/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Incyte USD 228.62M 1.41B Mar/2026
Ionis Pharmaceuticals USD 26.03M 2.05M Mar/2026
Merck USD 3.86B 541M Mar/2026
Moderna USD 161M 156M Mar/2026
Nektar Therapeutics USD 10.77M 4.79M Dec/2025
Novartis USD 4.32B 134M Mar/2026
Novartis USD 4.46B 99M Dec/2025
Pfizer USD 4.51B 734M Mar/2026
Puma Biotechnology USD 6.39M 962K Sep/2025
Regeneron Pharmaceuticals USD 1.03B 4.81B Mar/2026
Roche Holding CHF 5.78B 1.27B Dec/2025
Sarepta Therapeutics USD 70.38M 210.46M Mar/2026
Vertex Pharmaceuticals USD 3.47B 40.6M Mar/2026